【レポートの概要（一部）】
1. Report Overview
1.1 Global Translational Regenerative Medicine: Market Overview
1.2 Global Translational Regenerative Medicine Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered By This Analytical Report
1.6 Who Is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
1.10 About Visiongain
2. An Introduction To Translational Regenerative Medicine
2.1 What is Regenerative Medicine?
2.1.1 Translational Regenerative Medicine – From Bench To Bedside
2.2 Translational Regenerative Medicine – Market Breakdown
2.2.1 Stem Cell Therapy – Marketable Differentiation And Specialisation
2.2.1.1 How Embryonic Stem Cells (ESCs) Entered The Fray
2.2.1.2 Classifying Stem Cells by Potency
2.2.1.3 Stem Cells Categories: ESCs, SSCs, iPSCs
2.2.1.4 Parthenogenetic Stem Cells: Ethical ESC-Like Cells?
2.2.1.5 Autologous versus Allogeneic Stem Cells: Towards Universal Stem Cell Products?
2.2.2 Tissue Engineering – Invitro Manipulation For Therapeutic Purposes
2.2.3 Gene Therapies
2.2.3.1 Harnessing Infectivity: Viral Vectors in Gene Therapy
2.3 Other Approaches To Regenerative Medicine
2.3.1 Small Molecules and Proteins – Scaffold-Based Delivery Of Signalling Molecules
2.3.2 Cosmetic Applications of Regenerative Medicine
2.4 Regulation of Regenerative Medicine
2.4.1 Regulation of Regenerative Medicine Products in Europe
2.4.2 Regulation of Regenerative Medicine Products in the US
2.5 The Phases of Clinical Trials
2.6 Market Definition
2.6.1 Products Excluded From The Report
3. Translational Regenerative Medicine Market, 2015-2025
3.1 Global Translational Regenerative Medicine: Market Overview
3.1.1 Segments Within The Global Translational Regenerative Medicine Market
3.2 The Global Translational Regenerative Medicine Market In 2013 And 2014
3.3 Global Translational Regenerative Medicine: Market Forecast 2015-2025
3.3.1 Market Sectors That Will Drive Regenerative Medicine Growth
3.3.2 Global Translational Regenerative Medicine Market – Changing Market Shares By Sector 2015-2025
4. Stem Cell Therapies: Leading Applications, 2015-2025
4.1 The Global Market For Stem Cell Therapies, 2013 And 2014
4.1.1 Stem Cell Therapies: Currently Available Therapies
4.1.2 Haematopoietic Stem Cell Transplantation (HSCT)
4.1.3 Stem Cell Orthobiologics
4.2 Stem Cell Therapies: Global Market Forecast 2015-2025
4.3 AlloStem (AlloSource)
4.4 Osteocel Plus (NuVasive)
4.4.1 Osteocel Plus: Sales Forecast 2015-2025
4.5 Trinity ELITE and Trinity Evolution (Orthofix)
4.5.1 Trinity ELITE and Trinity Evolution: Sales Forecast, 2015-2025
4.6 PureGen (AlphaTec Spine)
4.7 Other Approved Stem Cell Therapy Products, 2015
4.7.1 Cartistem (Medipost)
4.7.2 Cupistem (Anterogen)
4.7.3 Hearticellgram-AMI (Pharmicell)
4.7.4 Prochymal/ Remestemcel-L (Mesoblast)
4.7.4.1 Prochymal/ Remestemcel-L: Sales Forecast 2015-2025
4.8 Development Pipeline For Stem Cell Therapies, 2015-2025
4.8.1 Late-Stage Pipeline for Stem Cell Therapies, 2015
4.8.1.1 StemEx (Gamida Cell)
4.8.1.2 Mesenchymal Precursor Cell Therapies (Mesoblast)
4.8.1.3 Adult Autologous CD34+ Cells (Baxter)
4.8.1.4 MyoCell (Bioheart)
4.8.1.5 Cx601 (TiGenix)
4.8.1.6 Adipose-Derived Stem Cells (Cytori Therapeutics)
4.8.1.7 Stempeucel (Stempeutics Research)
4.8.1.8 C-Cure (Cardio3 BioSciences)
4.8.1.9 Other Late-Stage Stem Cell Therapies
4.8.2 Diabetes And Stem Cell Therapy
4.8.2.1 Mesenchymal Precursor Cells (Mesoblast)
4.8.2.2 VC-01 (ViaCyte Inc)
4.8.2.2.1 Clinical Development Efforts For VC-01 For The Treatment Of Diabetes
4.8.3 Cardiovascular Disease And Stem Cell Therapy
4.8.3.1 Endometrial Regenerative Cells (MediStem, Intrexon)
4.8.3.2 AMR-001 (NeoStem)
4.8.3.3 CAP-1002 (Capricor)
4.8.4 Stem Cell Therapy in Cancer
4.8.4.1 CLT-008 (Cellerant Therapeutics)
4.8.4.2 OncoCyte/BioTime – Targeting Cancer With Gene And Stem Cell Therapy
4.8.5 Stem Cell Therapy For Central Nervous System (CNS) Conditions
4.8.5.1 NurOwn (BrainStorm Cell Therapeutics)
4.8.5.1.1 Clinical Development Efforts for NorOwn, 2015
4.8.5.2 NSI-566 (Neuralstem)
4.8.5.3 MultiStem (Athersys)
4.8.5.4 PDA-001 (Cenplacel-L, Celgene)
4.8.5.5 ALD-401 (Cytomedix)
4.8.5.6 ReN001 (ReNeuron)
4.8.6 Stem Cell Therapy for Eye Diseases
4.8.6.1 MA09-hRPE (Advanced Cell Technology)
4.8.6.2 HuCNS-SC (StemCells Inc.)
4.8.6.3 Collaboration And License Agreement Between Pfizer And The London Project to Cure Blindness
4.9 Stem Cells Therapy Market: Drivers and Restraints 2015-2025
5. Tissue Engineering Therapies: Leading Applications, 2015-2025
5.1 The Global Market For Tissue Engineered Therapies, 2013 And 2014
5.1.1 Tissue Engineering Therapies: Currently Available Therapies
5.2 Tissue Engineering Therapies: Global Market Forecast 2015-2025
5.3 Tissue Engineering In Wound Repair And Healing
5.3.1 Apligraf (Organogenesis)
5.3.1.1 Apligraf: Historical Sales Analysis
5.3.1.2 Apligraf: Sales Forecast 2015-2025
5.3.2 BioDfence and BioDfactor (BioD)
5.3.3 CureXcell (MacroCure)
5.3.4 Dermagraft (Organogenesis)
5.3.4.1 Dermagraft (Shire): Sales Forecast 2015-2025
5.3.5 Epicel (Aastrom)
5.3.6 Grafix (Osiris Therapeutics)
5.3.7 MySkin and CyroSkin (Regenerys)
5.3.8 ReCell (Avita Medical)
5.3.8.1 ReCell (Avita Medical): Sales Forecast 2015-2025
5.4 Tissue Engineering for Cartilage Repair
5.4.1 Autologous Chondrocyte Implantation (ACI)
5.4.2 Carticel (Aastrom Biosciences)
5.4.3 ChondroCelect (TiGenix, Sobi Partners)
5.4.4 DeNovo NT (Zimmer)
5.4.5 MACI (Aastrom Biosciences)
5.5 Other Available Tissue Engineering Therapies
5.5.1 Autologous Cultured Cell and Tissue Products (Japan Tissue Engineering Co.)
5.5.2 Gintuit (Organogenesis)
5.5.3 LAVIV (azficel-T), (Fibrocell Science)
5.5.4 Acellular Tissue Engineering Products
5.6 Tissue Engineering: Development Pipeline, 2015-2025
5.6.1 Pipeline Products For Autologous Chondrocyte Implantation
5.6.2 Tissue Engineering For Skin
5.6.3 Tissue Engineering for Liver Diseases
5.6.3.1 Extracorporeal Bio-Artificial Liver Therapy (Vital Therapies)
5.6.4 Tissue Engineering for Cardiovascular Disease
5.6.5 Tissue Engineering for Eye Diseases
5.7 Future Prospects for Organ Transplantation and Tissue Engineering
5.8 Tissue Engineered Products Market: Drivers and Restraints 2015-2025
6. Gene Therapies: Leading Applications, 2015-2025
6.1 The Global Market For Gene Therapies, 2013 And 2014
6.2 Gene Therapies: Global Market Forecast 2015-2025
6.3 Currently Available Gene Therapy Products
6.3.1 Gendicine (Benda Pharmaceutical)
6.3.2 Oncorine (Shanghai Sunway Biotech)
6.3.3 Neovasculgen (Human Stem Cells Institute)
6.3.3.1 Neovasculgen (HSCI): Sales Forecast 2015-2025
6.3.4 Glybera (UniQure)
6.3.4.1 Glybera: Sales Forecast 2015-2025
6.4 Development Pipeline For Gene Therapies, 2015-2025
6.4.1 Late-Stage Pipeline Gene Therapies, 2015
6.4.1.1 Collategene (beperminogene perplasmid) – (AnGes MG/Vical)
6.4.1.2 ProstAtak (AdV-tk) – (Advantagene)
6.4.1.3 Trinam (taberminogene vadenovec) – (Ark Therapeutics)
6.4.1.4 T-VEC (talimogene laherparepvec) – (Amgen)
6.4.1.4.1 Clinical Trials And Development Efforts For T-Vec
6.4.1.4.2 Talimogene Laherparepvec (T-Vec) – Sales Forecast 2015-2025
6.4.1.5 AAV2-hRPE65v2 (Spark Therapeutics)
6.4.1.6 CG0070 (Cold Genesys)
6.4.2 Gene Therapy For Use In The Treatment Of Diabetes
6.4.3 Gene Therapy Directed At Oncology Indications
6.4.4 Gene Therapy Directed At Neurological Diseases
6.4.5 Gene Therapy Directed At Tackling Haemophilia B
6.5 Gene Therapy Market: Drivers and Restraints 2015-2025
7. Leading National Markets for Translational Regenerative Medicine, 2015-2025
7.1 The Translational Regenerative Medicine Market By Region
7.1.1 The Global Distribution of Translational Regenerative Medicine In 2013 And 2014
7.2 Leading National Markets: Forecast 2015-2025
7.2.1 Changing Market Shares By Region, 2015-2025
7.3 Regional Translational Regenerative Medicine Markets: Analysis And Forecasts, 2015-2025
7.4 United States: The Largest Translational Regenerative Medicine Market
7.4.1 US Translational Regenerative Medicine Market: Market Drivers And Restraints, 2015-2025
7.4.2 US Translational Regenerative Medicine Market: Market Forecast 2015-2025
7.4.3 The Regulatory Framework For Regenerative Medicine In The US
7.4.4 The Impact Of Ethical And Regulatory Reluctance To Embryonic Stem Cell Research And Its Impact On Funding
7.4.5 How Is The Ending Of Patenting For Human Gene Products Affecting The Regenerative Medicine Market In The US?
7.5 Europe: A Fragmented Regenerative Medicine Market
7.5.1 European Regenerative Medicine Market: Market Drivers and Restraints, 2015-2025
7.5.2 European Regenerative Medicine Market: Market Forecast 2015-2025
7.5.3 Europe’s Unitary Patent System And Its Impact On The Future Of Regenerative Medicine In The Region
7.5.4 Regulation Of Regenerative Medicine In The European Union
7.5.5 UK: A Leading Research Centre For Regenerative Medicine In Europe
7.5.5.1 Regulation of Stem Cell Research In The UK
7.5.6 Russia: Rising Interest In Regenerative Medicine Research
7.6 Asia-Pacific: Accommodating Regulatory Landscape Aiding Rapid Product Commercialisation
7.6.1 Asia-Pacific Regenerative Medicine Market: Market Drivers and Restraints, 2015-2025
7.6.2 Asia-Pacific Regenerative Medicine Market: Market Forecast 2015-2025
7.6.3 Australia: Encouraging Translational Regenerative Medicine
7.6.4 China: Encouraging Stem Cell R&D
7.6.4.1 Government Intervention Into RM Research In China
7.6.4.2 Regulation Of Stem Cell Research In China
7.6.4.3 Commercialisation Of Gene Therapy And Tissue Engineering Products In China
7.6.4.4 Medical Tourism Impacting Market Growth For Regenerative Medicine In China
7.6.5 Japan: Difficulty In Translating Research Into Commercialisation
7.6.5.1 Research Funding: A Major Determinant Of Growth In Japan’s Regenerative Medicine
7.6.5.2 Government Interventions In Promoting Stem Cell Research In Japan
7.6.5.3 Regulation of Regenerative Medicine In Japan
7.6.6 India: An Emerging Market For Regenerative Medicine
7.6.6.1 Efforts In Stem Cell Research In India
7.6.6.2 Unclear Guidelines Hindering Progression Of Gene Therapy Research In India
7.6.7 South Korea: First to Approve Stem Cell Treatments
7.6.7.1 A Regeneration In South Korea’s Stem Cell Research Efforts
7.7 Rest of the World: Regenerative Medicine Conquering New Territories And Booming
7.7.1 Rest of the World Regenerative Medicine Market: Market Forecast 2015-2025
8. Leading Companies In The Translational Regenerative Medicine Market, 2015-2025
8.1 Translational Regenerative Medicine: A Hotbed For Innovation
8.2 Aastrom Biosciences
8.2.1 Aastrom’s Acquisition Of Sanofi’s Regenerative Medicine Business
8.2.2 Aastrom: Historical Financial And Performance Analysis, 2011-2013
8.2.3 Aastrom Regenerative Medicine Portfolio, 2015
8.2.4 Aastrom: Pipeline Analysis, 2015
8.3 Alphatec Spine
8.3.1 Alphatec Spine: Financial And Performance Analysis, 2009-2013
8.3.2 Alphatec Spine’s Shifting Focus From Regenerative Medicine To Medical Devices
8.4 Anterogen
8.4.1 Anterogen: Pipeline Analysis, 2015
8.5 Athersys
8.5.1 Athersys: Financial And Performance Analysis, 2010-2013
8.5.2 Athersys: Pipeline Analysis, 2015
8.5.2.1 MultiStem Technology – Potential Treatment For A Range Of Diseases
8.6 Avita Medical
8.6.1 Avita Medical: Historical Financial And Performance Analysis, 2013-2014
8.6.2 Avita Medical: Regenerative Medicine Portfolio, 2015
8.6.3 Avita Medical: Pipeline Analysis, 2015
8.7 AxoGen
8.7.1 AxoGen: Historical Financial And Performance Analysis, 2010-2013
8.7.2 AxoGen: Regenerative Medicine Portfolio, 2015
8.7.3 AxoGen: Pipeline Analysis, 2015
8.8 Medipost
8.8.1 Medipost: Historical Financial And Performance Analysis, 2011-2013
8.8.2 Medipost: Regenerative Medicine Portfolio, 2015
8.8.3 Medipost: Pipeline Analysis, 2015
8.9 Mesoblast
8.9.1 Mesoblast Product Portfolio, 2015
8.9.2 Mesoblast: Historical Financial And Performance Analysis, 2011-2014
8.9.3 Mesoblast: Pipeline Analysis, 2015
8.9.3.1 NeoFuse
8.9.3.2 Chondrogen
8.9.3.3 Prochymal
8.9.3.4 Other Recent Pipeline Acquisitions By Mesoblast
8.10 NuVasive
8.10.1 NuVasive Product Portfolio, 2015
8.10.2 NuVasive: Historical Financial And Performance Analysis, 2009-2013
8.10.3 NuVasive: Pipeline Analysis, 2015
8.11 Ocata Therapeutics
8.11.1 Ocata Therapeutics: Historical Financial And Performance Analysis, 2009-2013
8.11.2 Ocata Therapeutics: Pipeline Analysis, 2015
8.11.2.1 Retinal Pigment Epithelial Cell Therapy
8.11.2.2 Research Around iPSC-derived Platelets
8.11.2.3 Hemangioblast As A Treatment for Blood And Cardiovascular Diseases
8.11.2.4 Mesenchymal Stem Cell Program – Tissue Repair Functionalities
8.11.3 Ocata’s Other Therapeutic Platforms
8.12 Organogenesis
8.12.1 Organogenesis RM Portfolio, 2015
8.12.2 Organogenesis: Pipeline Analysis, 2015
8.13 Osiris Therapeutics
8.13.1 Osiris Therapeutics: RM Portfolio, 2015
8.13.2 Osiris Therapeutics: Historical Financial And Performance Analysis, 2010-2013
8.13.3 Osiris Therapeutics: Pipeline Analysis, 2015
8.14 Pharmicell
8.14.1 Pharmicell: Historical Financial And Performance Analysis, 2011-2013
8.14.2 Pharmicell: Pipeline Analysis, 2015
8.15 Regenerys
8.15.1 Regenerys: RM Portfolio, 2015
8.15.2 Regenerys: Pipeline Analysis, 2015
8.16 Shire
8.16.1 Shire: RM Portfolio, 2015
8.16.2 Shire: Historical Financial And Performance Analysis, 2010-2013
8.16.3 Shire: Pipeline Analysis, 2015
8.16.3.1 Vascugel
8.17 TiGenix
8.17.1 TiGenix: Historical Financial And Performance Analysis, 2011-2013
8.17.2 TiGenix: Pipeline Analysis, 2015
8.18 UniQure
8.18.1 UniQure: Pipeline Analysis, 2015
9. Qualitative Analysis for the Global Translational Regenerative Medicine Market, 2015-2025
9.1 Market Factors Influencing The Translational Regenerative Medicine Market
9.2 SWOT Analysis Of The Translation Market, 2015-2025
9.2.1 Strengths
9.2.1.1 Improvements In Regulatory Frameworks
9.2.1.2 Advancements In General Cellular And Tissue Research Aiding Regenerative Medicine
9.2.1.3 Strong Support From Governments In Multiple Regions
9.2.1.4 Increasing Ease Of Product Commercialisation And Market Access
9.2.2 Weaknesses
9.2.2.1 The High Price Of Regenerative Medicine Products May Restrain Market Growth
9.2.2.2 Lack Of Funding From Venture Capital
9.2.2.3 The Intrinsic Lack Of Standardisation Is A Burden To Scaling Up Manufacturing
9.2.2.4 Successful Commercialisation Of RM Products Requires New Business Models
9.2.3 Opportunities
9.2.3.1 3D Bioprinting And Other Technologies May Enable Rapid Scale-Up
9.2.3.2 Medical Tourism May Stimulate Standardisation And Drive Market Growth
9.2.3.3 Disruptive Regenerative Medicine Therapies Can Create New Markets
9.2.4 Threats
9.2.4.1 Ethical Concerns Limiting R&D In Regenerative Medicine
9.2.4.2 Difficulty Establishing An Evidence Base For Long-Term Efficacy Of RM Therapies
9.2.4.3 Rate Of Scientific Progress – A Major Determinant Of RM Market Growth
9.2.4.4 Restraints On Reimbursement May Slow Growth
9.3 Porter’s Five Force Analysis Of The Translational Regenerative Medicine Market, 2015-2025
9.3.1 Threat Of New Entrants
9.3.2 Threat Of Substitutes
9.3.3 Power Of Suppliers
9.3.4 Power Of Buyers
9.3.5 Rivalry Among Competitors
10. Expert Opinions from Our Primary Research
10.1 Interview With Antonio S J Lee Ph.D, CEO & Managing Director For MEDIPOST America Inc.
10.1.1 MEDIPOST And Recent Developments In Regenerative Medicine
10.1.2 The Transition From Mid- To Late-Stage Clinical Trials In The RM Market And Its Likely Implications
10.1.3 CARTISTEM®, PNEUMOSTEM®, NEUROSTEM® – Medipost’s Development Plans In Regenerative Medicine
10.1.4 Cord Blood Banking And Korea’s Role In Its Advancement
10.1.5 The Role Of R&D Strategies And Long-Term Efficacy Data In The Future Success Of Regenerative Medicine
10.1.6 The Role Of Big-Pharma Companies In Regenerative Medicine And The Need For Regulatory Harmonisation
10.1.7 On The Unmet Needs For Regenerative Medicine To Target
10.1.8 On The Future Developments To Expect In The Market For Regenerative Medicine Over The Next Decade
11. Conclusions
11.1 Overview Of Current Market Conditions And Market Forecast, 2013-2025
11.2 Leading Regenerative Medicine Segments In 2013
11.3 Leading Regions In The Translational Regenerative Medicine Market In 2013 And 2014
11.4 Future Outlook For The Various Sectors Within TRM, 2015-2025
11.5 R&D Pipeline Products Crucial To Future Market Growth
11.6 What Does The Future Hold For Regenerative Medicine?
【レポート販売概要】
■ タイトル：トランスレーショナル再生医療の世界市場：幹細胞治療、ティッシュ・エンジニアリング治療、遺伝子治療■ 英文：Translational Regenerative Medicine: Market Prospects 2015-2025
■ 発行日：2015年2月
■ 調査会社：visiongain
■ 商品コード：VGAIN5020411
■ 調査対象地域：世界
- スマートごみ箱の世界市場2017-2021About Smart Trash Bin The global smart trash bin market has been registering positive growth over the last few years and is shaping up to become one of the top competitive markets at a global level. With the rise in globalization, ample growth opportunities are being created in the market. Technavio’s analysts forecast the global smart trash bin market to grow at a CAGR of 16.48% during the period …
- 屋外動力装置の世界市場展望2017-2026According to Stratistics MRC, the Global Outdoor Power Equipment Market is accounted for $20.34 billion in 2017 and is expected to reach $30.75 billion by 2026 growing at a CAGR of 4.7% during the forecast period. Increasing demand for landscaping services, growing use of power tools for construction purposes and rising in the battery-powered equipment are some of the factors fuelling the market g …
- リングメインユニット（RMU）の世界市場予測（～2022年）The global ring main unit market is projected to grow at a CAGR of 8.35% from 2017 to 2022, to reach a market size of USD 2.45 Billion by 2022. This growth is attributed to modernization of existing power infrastructure and huge electricity demand in developing countries. Investments for renewable power generation in Asia-Pacific countries have been planned to meet the rising power demand. These i …
- 銅市場：ウクライナThis report is a comprehensive research of woodworking industry in Ukraine. The first two chapters of the report feature the country profile by giving general information on Ukraine and by thoroughly studying its economic state, (including key macroeconomic indicators and their development trends). The third chapter covers common business procedures in the country: from starting a project to closi …
- ペットフード加工の世界市場予測（～2022年）：加工装置（混合装置、成形機械、ベーキング装置、乾燥装置）、動物（犬、猫、その他）The global pet food processing market, by equipment, has grown considerably in the last few years. The market size of pet food processing equipment is projected to reach USD 4.27 Billion by 2022, at a CAGR of around 3.5% from 2016. Pet food manufacturers demand new and automated pet food processing machineries in order to ensure an uninterrupted production flow. Increasing usage of processed & pac …
- DC-DCコンバータの世界市場予測（～2021年）The DC-DC converters market is expected to grow from USD 3.46 Billion in 2016 to USD 3.94 Billion by 2021, at a CAGR of 2.66%. Factors, such as growing concern towards global energy consumption, introduction of advanced power saving architectures, increasing demand in current requirements by the ICT industry, and the emergence of digital power management and control technologies are expected to dr …
- 世界の医療用セラミック市場動向（2012-2016）TechNavio’s analysts forecast the Global Medical Ceramics market to grow at a CAGR of 4.25 percent over the period 2012-2016. One of the key factors contributing to this market growth is the growing demand for cosmetic dentistry. The Global Medical Ceramics market has also been witnessing its application in hip replacement implants. However, threat of brand loyalty to small companies could pose a …
- 創傷閉鎖デバイスのグローバル製品パイプライン動向2015Wound Closure Devices - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, “Wound Closure Devices - Pipeline Review, 2015" provides an overview of Wound Closure Devices currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players …
- 世界のエピペン市場2015The Global Epinephrine Autoinjector Industry Report 2015 is a professional and in-depth study on the current state of the Epinephrine Autoinjector industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Epinephrine Autoinjector market analysis is provided for the international markets including development …
- 防護服の世界市場2016-2020About PPE Personal protective equipment (PPE) is worn to minimize the wearers’ exposure to hazards. PPE finds application in a number of industries such as manufacturing, chemicals, construction, oil and gas, food, pharmaceuticals, and others. PPE is used to reduce health and safety risks not only at the workplace but also in sports and other recreational activities. The selection of PPE depends o …
- 使い捨てバイオリアクターの世界市場：波誘発動使い捨てバイオリアクター、攪拌槽使い捨てバイオリアクター、使い捨て気泡塔バイオリアクターDeveloping markets such as China and India are lucrative markets for single-use bioreactors (SUB), owing to the low cost benefits offered by these nations. The report segments the global SUB market by molecule type, type of cell, technology, end user, and region. The monoclonal antibodies (MAbs) segment accounted for the lion’s share of the global SUB market, by molecule type. However, the stem ce …
- Gulfport Energy Corporation：石油・ガスの開発・生産動向及びコスト分析– Q1, 2013Gulfport Energy Corporation Oil & Gas Exploration and Production Operations and Cost Analysis – Q1, 2013 Summary Gulfport Energy Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an esse …
- 農業機械の世界市場2016-2020About the Agricultural Machinery Market Growing global population and increase in per capita income in emerging economies lead to a rise in the demand for food products. The world population is estimated to reach 9.48 billion by 2050 from 7.4 billion in 2016. As a result, farmers are shifting toward mechanization through the use of agricultural machinery, to gain efficiency and effectiveness in fa …
- 組立ライン用ロボットの世界市場2016-2020Technavio research analyst predicts the global assembly line robots market to grow steadily at a CAGR of 7% during the forecast period. The need for flexibility in plant operations is one of the primary drivers of the market. As most industries now serve their customers 24/7, employees are required to work round the clock. The adoption of robots has reduced the employee workload drastically. Monot …
- 世界のラゲッジ（手荷物）市場動向（2012-2016）TechNavio’s analysts forecast the Global Luggage market to grow at a CAGR of 8.1 percent CAGR over the period 2012-2016. One of the key factors contributing to this market growth is the increasing disposable income of the consumers. The Global Luggage market has also been witnessing a trend of an increased per capita expenditure on luggage by the consumers. However, the increasing competition from …
